Get started
Markets US Stocks Health Technology Biotechnology

Phio Pharmaceuticals Corp PHIO

PHIO NASDAQ
PHIO
Phio Pharmaceuticals Corp NASDAQ
See more on advanced chartSee more on advanced chart
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
See more on advanced chartSee more on advanced chart
Overview
News Ideas Financials Technicals

PHIO Stock Chart

Get $150 worth of Bitcoin from TradeStation Crypto with a new account. Start trading

Ideas

Videos only
$PHIO is gonna fall today
PHIO
, 15 Short
PHIO: $PHIO is gonna fall today

Pupm&Dump trading strategy idea. $PHIO is rising too much today. The demand for shares of the company looks lower than the supply. This and other conditions can cause a fall in the share price today. So I opened a short position from $2,34; stop-loss — $2,50; take-profit — $2,02/MOC Do not view this idea as a recommendation for trading or investing. It is...

short term +1,000% (distribution phase)
PHIO
, 1D
PHIO: short term +1,000% (distribution phase)

will pump very fast

PHIO long
PHIO
, 1D
Long
PHIO: PHIO long

PHIO is very compressed

$PHIO is gonna fall today
PHIO
, 15 Short
PHIO: $PHIO is gonna fall today

Pupm&Dump trading strategy idea. $PHIO is rising without clear preconditions today. The demand for shares of the company looks lower than the supply. This and other conditions can cause a fall in the share price today. So I opened a short position from $2,75; stop-loss — $3,19; take-profit — $2,31; Do not view this idea as a recommendation for trading or...

Phio Long Trade Idea
PHIO
, 120
PHIO: Phio Long Trade Idea

Phio Long Trade Idea

PHIO supp x res
PHIO
, 1D
PHIO: PHIO supp x res

PHIO - keep in mind of the event going into the week

PHIO
PHIO
, 1D
Long
PHIO: PHIO

Phio Pharmaceuticals Corp Targets $phio
PHIO
, 240
Long
PHIO: Phio Pharmaceuticals Corp Targets $phio

Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics that address unmet medical needs. Its clinical product candidate includes RXI-109, a RNAi compound developed for the reduction of dermal scarring in planned surgeries. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.

Technicals

Financials

Valuation
Enterprise Value/EBITDA, TTM —
Enterprise Value, FQ —
Market Cap — Basic —
Number of Employees —
Number of Shareholders —
Price/Earnings, TTM —
Price/Revenue, TTM —
Price/Book Ratio, FY —
Price/Sales Ratio, FY —
Balance Sheet
Current Ratio, FQ —
Debt to Equity, FQ —
Net Debt, FQ —
Quick Ratio, FQ —
Total Assets, FQ —
Total Debt, FQ —
Operating Metrics
Return on Assets, TTM —
Return on Equity, TTM —
Return on Invested Capital, TTM —
Revenue per Employee, TTM —
Price History
Average Volume (10 day) —
Beta - 1 Year —
Price - 52 Week High —
Price - 52 Week Low —
Dividends
Dividends Paid, FY —
Dividends per Share, FY —
Expected Annual Dividends —
Dividends Yield —
Margins
Net Margin, TTM —
Gross Margin, TTM —
Operating Margin, TTM —
Pretax Margin, TTM —
Income Statement
Basic EPS, Net Income —
Earnings per Share, Basic, TTM —
EBITDA, TTM —
Gross Profit, FY —
Last Annual EPS —
Last Annual Revenue, FY —
Net Income, FY —
Total Revenue, FY —
Free Cash Flow, TTM —
More financials

Profile

Sector: Health Technology
Industry: Biotechnology
Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics that addresses unmet medical needs. Its clinical product candidate includes RXI-109, an RNAi compound developed for the reduction of dermal scarring in planned surgeries. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.

Breaking news

More news